(DKNG) DraftKings - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US26142V1052
Stock: Sports Betting, Fantasy Sports, Online Casino, Gaming Software
Total Rating 21
Risk 37
Buy Signal -1.38
| Risk 5d forecast | |
|---|---|
| Volatility | 48.9% |
| Relative Tail Risk | -0.82% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.75 |
| Alpha | -64.47 |
| Character TTM | |
|---|---|
| Beta | 1.635 |
| Beta Downside | 1.966 |
| Drawdowns 3y | |
|---|---|
| Max DD | 59.32% |
| CAGR/Max DD | 0.19 |
EPS (Earnings per Share)
Revenue
Risks
Technicals:
volatile
Description: DKNG DraftKings March 02, 2026
DraftKings Inc. (NASDAQ: DKNG) is a digital sports entertainment and gaming firm that offers online and retail sports betting, daily fantasy sports, digital lottery, prediction markets, and iGaming products such as blackjack, roulette, baccarat, and slots. It also licenses its betting and casino software to other operators and runs retail sportsbooks.
In the most recent quarter (Q2 2024), DraftKings generated $1.32 billion in revenue, a 15% year-over-year increase, while its monthly active customers rose to 7.4 million, pushing average revenue per user (ARPU) to $16.5. The company posted an adjusted EBITDA loss of $120 million, reflecting continued investment in market expansion and technology.
Key sector drivers include the rapid rollout of sports-betting legalization across additional U.S. states-bringing the total to 35 jurisdictions-as well as strong discretionary-spending trends and mobile-first consumer behavior, which together lifted the U.S. sports-betting handle by 13% YoY in Q2 2024.
For a deeper dive into DKNG’s valuation metrics, you might explore the analysis on ValueRay.
Headlines to watch out for
- State-level legalization of online sports betting expands addressable market
- iGaming growth boosts higher-margin revenue streams
- Marketing and promotional spending impacts profitability
- Regulatory changes in key states introduce operational uncertainty
- Economic downturn reduces discretionary consumer spending on gaming
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 3.71m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.14 > 0.02 and ΔFCF/TA 5.48 > 1.0 |
| NWC/Revenue: 0.98% < 20% (prev -2.54%; Δ 3.53% < -1%) |
| CFO/TA 0.15 > 3% & CFO 662.9m > Net Income 3.71m |
| Net Debt (329.6m) to EBITDA (355.7m): 0.93 < 3 |
| Current Ratio: 1.03 > 1.5 & < 3 |
| Outstanding Shares: last quarter (532.0m) vs 12m ago 9.02% < -2% |
| Gross Margin: 41.25% > 18% (prev 0.38%; Δ 4.09k% > 0.5%) |
| Asset Turnover: 137.4% > 50% (prev 111.3%; Δ 26.08% > 0%) |
| Interest Coverage Ratio: 1.92 > 6 (EBITDA TTM 355.7m / Interest Expense TTM 41.7m) |
Altman Z'' -6.15
| A: 0.01 (Total Current Assets 1.82b - Total Current Liabilities 1.76b) / Total Assets 4.53b |
| B: -1.42 (Retained Earnings -6.44b / Total Assets 4.53b) |
| C: 0.02 (EBIT TTM 80.2m / Avg Total Assets 4.41b) |
| D: -1.64 (Book Value of Equity -6.40b / Total Liabilities 3.90b) |
| Altman-Z'' Score: -6.15 = D |
Beneish M -3.34
| DSRI: 0.69 (Receivables 105.6m/120.4m, Revenue 6.05b/4.77b) |
| GMI: 0.92 (GM 41.25% / 38.11%) |
| AQI: 0.94 (AQ_t 0.58 / AQ_t-1 0.61) |
| SGI: 1.27 (Revenue 6.05b / 4.77b) |
| TATA: -0.15 (NI 3.71m - CFO 662.9m) / TA 4.53b) |
| Beneish M-Score: -3.34 (Cap -4..+1) = AA |
What is the price of DKNG shares?
As of March 18, 2026, the stock is trading at USD 25.22 with a total of 13,984,224 shares traded.
Over the past week, the price has changed by +0.32%, over one month by +11.64%, over three months by -25.93% and over the past year by -34.88%.
Over the past week, the price has changed by +0.32%, over one month by +11.64%, over three months by -25.93% and over the past year by -34.88%.
Is DKNG a buy, sell or hold?
DraftKings has received a consensus analysts rating of 4.47.
Therefore, it is recommended to buy DKNG.
- StrongBuy: 20
- Buy: 7
- Hold: 5
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the DKNG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 36.4 | 44.4% |
| Analysts Target Price | 36.4 | 44.4% |
DKNG Fundamental Data Overview March 17, 2026
P/E Forward = 19.8807
P/S = 2.1269
P/B = 20.1971
P/EG = 0.083
Revenue TTM = 6.05b USD
EBIT TTM = 80.2m USD
EBITDA TTM = 355.7m USD
Long Term Debt = 1.84b USD (from longTermDebt, last quarter)
Short Term Debt = 9.79m USD (from shortTermDebt, last quarter)
Debt = 1.93b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 329.6m USD (from netDebt column, last quarter)
Enterprise Value = 13.21b USD (12.88b + Debt 1.93b - CCE 1.60b)
Interest Coverage Ratio = 1.92 (Ebit TTM 80.2m / Interest Expense TTM 41.7m)
EV/FCF = 21.57x (Enterprise Value 13.21b / FCF TTM 612.4m)
FCF Yield = 4.64% (FCF TTM 612.4m / Enterprise Value 13.21b)
FCF Margin = 10.11% (FCF TTM 612.4m / Revenue TTM 6.05b)
Net Margin = 0.06% (Net Income TTM 3.71m / Revenue TTM 6.05b)
Gross Margin = 41.25% ((Revenue TTM 6.05b - Cost of Revenue TTM 3.56b) / Revenue TTM)
Gross Margin QoQ = 45.98% (prev 31.46%)
Tobins Q-Ratio = 2.91 (Enterprise Value 13.21b / Total Assets 4.53b)
Interest Expense / Debt = 0.28% (Interest Expense 5.43m / Debt 1.93b)
Taxrate = 6.92% (10.1m / 146.6m)
NOPAT = 74.6m (EBIT 80.2m * (1 - 6.92%))
Current Ratio = 1.03 (Total Current Assets 1.82b / Total Current Liabilities 1.76b)
Debt / Equity = 3.06 (Debt 1.93b / totalStockholderEquity, last quarter 631.5m)
Debt / EBITDA = 0.93 (Net Debt 329.6m / EBITDA 355.7m)
Debt / FCF = 0.54 (Net Debt 329.6m / FCF TTM 612.4m)
Total Stockholder Equity = 811.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.08% (Net Income 3.71m / Total Assets 4.53b)
RoE = 0.46% (Net Income TTM 3.71m / Total Stockholder Equity 811.6m)
RoCE = 3.03% (EBIT 80.2m / Capital Employed (Equity 811.6m + L.T.Debt 1.84b))
RoIC = 2.82% (NOPAT 74.6m / Invested Capital 2.65b)
WACC = 10.41% (E(12.88b)/V(14.81b) * Re(11.94%) + D(1.93b)/V(14.81b) * Rd(0.28%) * (1-Tc(0.07)))
Discount Rate = 11.94% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 6.61%
[DCF] Terminal Value 60.19% ; FCFF base≈505.1m ; Y1≈331.6m ; Y5≈151.3m
[DCF] Fair Price = 3.59 (EV 2.10b - Net Debt 329.6m = Equity 1.77b / Shares 493.0m; r=10.41% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 81.10 | EPS CAGR: 48.68% | SUE: 0.49 | # QB: 0
Revenue Correlation: 91.27 | Revenue CAGR: 51.67% | SUE: 0.35 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.39 | Chg7d=-0.003 | Chg30d=-0.059 | Revisions Net=-3 | Analysts=9
EPS current Year (2026-12-31): EPS=1.24 | Chg7d=+0.003 | Chg30d=-0.325 | Revisions Net=-9 | Growth EPS=+88.5% | Growth Revenue=+14.0%
EPS next Year (2027-12-31): EPS=1.95 | Chg7d=+0.060 | Chg30d=-0.108 | Revisions Net=-8 | Growth EPS=+56.8% | Growth Revenue=+13.9%
[Analyst] Revisions Ratio: -1.00 (0 Up / 3 Down within 30d for Next Quarter)
P/S = 2.1269
P/B = 20.1971
P/EG = 0.083
Revenue TTM = 6.05b USD
EBIT TTM = 80.2m USD
EBITDA TTM = 355.7m USD
Long Term Debt = 1.84b USD (from longTermDebt, last quarter)
Short Term Debt = 9.79m USD (from shortTermDebt, last quarter)
Debt = 1.93b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 329.6m USD (from netDebt column, last quarter)
Enterprise Value = 13.21b USD (12.88b + Debt 1.93b - CCE 1.60b)
Interest Coverage Ratio = 1.92 (Ebit TTM 80.2m / Interest Expense TTM 41.7m)
EV/FCF = 21.57x (Enterprise Value 13.21b / FCF TTM 612.4m)
FCF Yield = 4.64% (FCF TTM 612.4m / Enterprise Value 13.21b)
FCF Margin = 10.11% (FCF TTM 612.4m / Revenue TTM 6.05b)
Net Margin = 0.06% (Net Income TTM 3.71m / Revenue TTM 6.05b)
Gross Margin = 41.25% ((Revenue TTM 6.05b - Cost of Revenue TTM 3.56b) / Revenue TTM)
Gross Margin QoQ = 45.98% (prev 31.46%)
Tobins Q-Ratio = 2.91 (Enterprise Value 13.21b / Total Assets 4.53b)
Interest Expense / Debt = 0.28% (Interest Expense 5.43m / Debt 1.93b)
Taxrate = 6.92% (10.1m / 146.6m)
NOPAT = 74.6m (EBIT 80.2m * (1 - 6.92%))
Current Ratio = 1.03 (Total Current Assets 1.82b / Total Current Liabilities 1.76b)
Debt / Equity = 3.06 (Debt 1.93b / totalStockholderEquity, last quarter 631.5m)
Debt / EBITDA = 0.93 (Net Debt 329.6m / EBITDA 355.7m)
Debt / FCF = 0.54 (Net Debt 329.6m / FCF TTM 612.4m)
Total Stockholder Equity = 811.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.08% (Net Income 3.71m / Total Assets 4.53b)
RoE = 0.46% (Net Income TTM 3.71m / Total Stockholder Equity 811.6m)
RoCE = 3.03% (EBIT 80.2m / Capital Employed (Equity 811.6m + L.T.Debt 1.84b))
RoIC = 2.82% (NOPAT 74.6m / Invested Capital 2.65b)
WACC = 10.41% (E(12.88b)/V(14.81b) * Re(11.94%) + D(1.93b)/V(14.81b) * Rd(0.28%) * (1-Tc(0.07)))
Discount Rate = 11.94% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 6.61%
[DCF] Terminal Value 60.19% ; FCFF base≈505.1m ; Y1≈331.6m ; Y5≈151.3m
[DCF] Fair Price = 3.59 (EV 2.10b - Net Debt 329.6m = Equity 1.77b / Shares 493.0m; r=10.41% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 81.10 | EPS CAGR: 48.68% | SUE: 0.49 | # QB: 0
Revenue Correlation: 91.27 | Revenue CAGR: 51.67% | SUE: 0.35 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.39 | Chg7d=-0.003 | Chg30d=-0.059 | Revisions Net=-3 | Analysts=9
EPS current Year (2026-12-31): EPS=1.24 | Chg7d=+0.003 | Chg30d=-0.325 | Revisions Net=-9 | Growth EPS=+88.5% | Growth Revenue=+14.0%
EPS next Year (2027-12-31): EPS=1.95 | Chg7d=+0.060 | Chg30d=-0.108 | Revisions Net=-8 | Growth EPS=+56.8% | Growth Revenue=+13.9%
[Analyst] Revisions Ratio: -1.00 (0 Up / 3 Down within 30d for Next Quarter)